. Author manuscript; available in PMC: 2013 Oct 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):171–178. doi: 10.1097/QAI.0b013e31826741aa

Table 1. HIV Quality of Care Indicators.

Quality indicators were assessedfor each participantin the 12 months following theirbaseline surveydate.

Quality Indicator	“Pass” Criteria	Eligibility Criteria
Medications
ART	Receipt of ART in past 12 months	CD4 nadir ≤ 350 cells/mL³ever
PCP proph	Receipt of dapsone, tmp/smx, atovaquone, pentamidine in 12 months	CD4 count ≤ 200 cells/mL³ in 12 months
MAC proph	Receipt of clarithromycin, azithromycin, or rifabutin in 12 months	CD4 count ≤ 50 cells/mL³ in 12 months
Screening
Hyperlipidemia	Lipid test in 12 months	On ART
Hepatitis C	Hepatitis C antibody or RNA test, ever	All
Prevention
Pneumovax	Pneumococcal vaccine, ever	All
Influenza	Influenza vaccine in 12 months	All
Monitoring
CD4	≥ 2CD4 counts performed in 12 months, at least 90 days apart	All
HIV Visits	≥ 2 HIV clinic visits in 12 months, at least 90 days apart	All